Browsing Tag

Autolus Limited

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology…

Eli Pacheco May 13, 2022 0

- AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma- AUTO1/22: oral presentation on initial experience in r/r pediatric B-cell acute lymphoblastic…

Health

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus’ CAR…

Eli Pacheco Apr 25, 2022 0

LONDON, April 25, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies,…

Health

Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to…

Eli Pacheco Nov 8, 2021 0

– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country – Durability and favorable toxicity…

Health

Autolus Therapeutics Presents New Data on obe-cel in r/r Indolent B Cell Lymphomas…

Eli Pacheco Jun 11, 2021 0

Obe-cel achieves 100% complete remission rate in a cohort of indolent B Cell Non-Hodgkin lymphoma patients with excellent CAR T engraftment, expansion, and persistence No ICANS or high…